Skip to content

Public FDA record

Z-0200-2015: Oxoid Legionella BCYE Growth Supplement SR0110A, packaged in 100 ml vials, 10/pkg. A growth suppleme

Recall record Z-0200-2015 for Remel Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0200-2015
Company in FDA record
Remel Inc
FDA classification date
Nov 10, 2014
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Recalled product may not provide adequate recovery of Legionella pneumophila when used as directed and may result in false negative identification of Legionella pneumophila.

Source facts

Action
Thermo Fisher sent an Urgent Medical Device Recall letter dated October 17, 2014, to all affected customers.
Initiated
2014-10-17
Root cause
Under Investigation by firm
Terminated
2017-02-13
Distribution
Distributed in the states of ND, VT and TX.
Recall number
Z-0200-2015
Recall status
Terminated
CDRH record ID
130810
FDA classified
2014-11-10
Recall event number
69521

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗